BeiGene Ltd

For the period ended Dec 31, 2024. Filed Feb 27, 2025.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Feb 27, 2025

ONC$424.00+1.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated balance sheets as of December 31, 202 and

CONSOLIDATED BALANCE SHEETS

	As of December 31,
	Note	2024	2023
$ · $
Assets
Current assets:
Cash and cash equivalents		2,627,410	3,171,800
Accounts receivable, net		676,278	358,027
Inventories, net	6	494,986	416,122
Prepaid expenses and other current assets	11	192,919	257,465
Total current assets		3,991,593	4,203,414
Property, plant and equipment, net	8	1,578,423	1,324,154
Operating lease right-of-use assets	7	139,309	95,207
Intangible assets, net	9	51,095	57,138
Other non-current assets	11	160,490	125,362
Total non-current assets		1,929,317	1,601,861
Total assets		5,920,910	5,805,275
Liabilities and shareholders’ equity
Current liabilities:
Accounts payable		404,997	315,111
Accrued expenses and other payables	11	803,713	693,731
Tax payable	10	25,930	22,951
Operating lease liabilities, current portion	7	17,576	21,950
Research and development cost share liability, current portion	3	111,154	68,004
Short-term debt	12	851,529	688,366
Total current liabilities		2,214,899	1,810,113
Non-current liabilities:
Long-term debt	12	166,484	197,618
Operating lease liabilities, non-current portion	7	44,277	22,251
Deferred tax liabilities	10	42,007	16,494
Research and development cost share liability, non-current portion	3	54,286	170,662
Other long-term liabilities	11	66,735	50,810
Total non-current liabilities		373,789	457,835
Total liabilities		2,588,688	2,267,948
Commitments and contingencies	20
Shareholders’ equity:
Ordinary shares, 0.0001 par value per share; 9,500,000,000 shares authorized; 1,387,367,704 and 1,359,513,224 shares issued and outstanding as of December 31, 2024 and 2023, respectively		138	135
Additional paid-in capital		12,087,908	11,598,688
Accumulated other comprehensive loss	16	(148,988)	(99,446)
Accumulated deficit		(8,606,836)	(7,962,050)
Total shareholders’ equity		3,332,222	3,537,327
Total liabilities and shareholders’ equity		5,920,910	5,805,275

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.